Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study.


Journal

Urologic oncology
ISSN: 1873-2496
Titre abrégé: Urol Oncol
Pays: United States
ID NLM: 9805460

Informations de publication

Date de publication:
01 2019
Historique:
received: 31 05 2018
revised: 10 10 2018
accepted: 05 11 2018
pubmed: 27 11 2018
medline: 6 3 2019
entrez: 27 11 2018
Statut: ppublish

Résumé

Partial nephrectomy (PN) is standard for small renal masses, improving renal function by preserving renal parenchyma compared with radical nephrectomy. Recent work demonstrated that postoperative surgeon assessment of volume preservation (SAVP) and 3D imaging measurements agree and correlate with postoperative function. We hypothesize preoperative assessment of volume preservation (PAVP) with PN based on preoperative imaging will reliably indicate postoperative renal function. Data were collected from 336 patients undergoing PN for suspected renal cancer by 40 surgeons at 12 centers in Europe and the United States within the Surface-Intermediate-Base International Consortium. Surgeons recorded PAVP and SAVP for individual patients; pre- and postoperative glomerular filtration rate (GFR) was estimated by Chronic Kidney Disease Epidemiology Collaboration equations. Correlations between PAVP, SAVP, and postoperative GFR were assessed with linear regression models. Bland-Altman analysis was used to assess agreement between PAVP and SAVP with a significant cutoff of 5%. Median PAVP was 90% (interquartile range [IQR] 85%-100%) and SAVP was 90% (IQR: 80%-94%). PAVP and SAVP were moderately correlated (R Renal function is closely linked to the amount of parenchymal volume preservation, whether estimated prior to surgery (PAVP) or afterward (SAVP). PAVP provides reasonably accurate information for decision-making in patients considering PN.

Identifiants

pubmed: 30473205
pii: S1078-1439(18)30453-8
doi: 10.1016/j.urolonc.2018.11.007
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-39

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

Michael J Klingler (MJ)

Michigan State University College of Human Medicine, Grand Rapids, MI.

Stephen K Babitz (SK)

Spectrum Health Hospital System, Grand Rapids, MI.

Alexander Kutikov (A)

Fox Chase Cancer Center, Philadelphia, PA.

Riccardo Campi (R)

Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.

Georgios Hatzichristodoulou (G)

University Hospital Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Francesco Sanguedolce (F)

Department of Urology, Southmead Hospital-North Bristol NHS Trust, Bristol, United Kingdom; Fundacio Puigvert, Autonomous University of Barcelona, Spain.

Sabine Brookman-May (S)

Janssen Research & Development, Global Clinical Operations Germany; Department of Urology, Ludwig-Maximilians-University, Munich, Germany.

Bulent Akdogan (B)

Faculty of Medicine, Department of Urology, Hacettepe University, Ankara, Turkey.

Umberto Capitanio (U)

Department of Urology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Marco Roscigno (M)

Department of Urology, AO Papa Giovanni XXIII, Bergamo, Italy.

Alessandro Volpe (A)

Division of Urology, Maggiore della Carita' Hospital, University of Eastern Piedmont, Novara, Italy.

Martin Marszalek (M)

Department of Urology, Graz Medical University, Graz, Austria.

Robert G Uzzo (RG)

Fox Chase Cancer Center, Philadelphia, PA; Albert Einstein Medical Center, Philadelphia, PA.

Alessandro Antonelli (A)

Department of Urology, Spedali Civili Hospital, University of Brescia, Brescia, Italy.

Johan Langenhuijsen (J)

Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.

Marco Carini (M)

Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.

Andrea Minervini (A)

Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.

Brian R Lane (BR)

Michigan State University College of Human Medicine, Grand Rapids, MI; Spectrum Health Hospital System, Grand Rapids, MI. Electronic address: brian.lane@spectrumhealth.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH